Biotica

Biotica discovers and develops novel polyketide therapeutics to create new medicines for serious diseases. Bioticas R&D pipeline is focused on optimised polyketide therapeutics for high-value indications. Bioticas compounds, generated using the proprietary novoPTTM technology, have unique chemistry and differentiated properties. Polyketides are the basis of more than 40 successful therapeutics in a wide range of diseases. They make excellent leads for drug discovery, with naturally high affinity to biologically relevant targets, including protein-protein interactions and other traditionally difficult targets. Biotica has formed successful partnerships with leading pharmaceutical companies, most recently Wyeth and GSK, based on its high-value projects. Projects are...

Polyketides,drug discovery,and pharmaceuticals

Biotica operates in the Biotechnology research industry.

Biotica's revenue is 11m - 100m

Biotica has 11 - 50 employees.